🇫🇷 Valbiotis SAS
ALVAL.PAFundamentals
Gross Margin
56.8%
Op. Margin
-88.5%
Net Margin
-91.8%
ROIC
-1450.2%
Rev Growth
417.1%
Valuation
Price
0.81 EUR
Day
+2.53%
52-Week Range
0.54 - 1.30
Market Cap
29M EUR
Fwd P/E
-
EV/EBITDA
-
Div Yield
-
Annual income statement #
Valbiotis SAS annual revenue, operating income and net income in EUR, 2016 to 2025. Revenue was 905,000 in 2025.
| Year | Revenue (EUR) | Operating income | Net income | Net margin |
|---|---|---|---|---|
| 2025 | 905,000 | -9.5m | -9.4m | |
| 2024 | 175,000 | -10.4m | -10.0m | |
| 2023 | 4.7m | -7.2m | -7.4m | |
| 2022 | 785,000 | -14.1m | -12.3m | |
| 2021 | 298,000 | -10.9m | -8.7m | |
| 2020 | 3.1m | -5.4m | -3.8m | |
| 2019 | 91,000 | -7.0m | -5.5m | |
| 2018 | 79,000 | -4.8m | -5.0m | |
| 2017 | 3,000 | -2.4m | -2.4m | |
| 2016 | 646,000 | -572,000 | -593,000 | -91.8% |
Financial Data #
Segment Breakdown #
Peers #
ALMER.PA STM.VI OTM.WA FODELIA.HE FHB.WA BIO.VI SNX.ST BIP.WA ALPOU.PA PPS.WA ·
Compare in Screener
Dividends
Bubble
Events #
| Date | Type | Details | Price | Amount |
|---|